Navigation Links
Vet-Stem and Central Veterinary Research Labs of Dubai Sign Exclusive License
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire/ -- Vet-Stem, Inc., the global leader in regenerative veterinary medicine, has licensed their proprietary stem cell technology to the Central Veterinary Research Laboratory (CVRL) of Dubai in the United Arab Emirates. The license allows the laboratory to offer adipose- derived stem cell services to animal owners throughout the Middle East region. The ruler of Dubai and Prime Minister of the United Arab Emirates, Sheik Mohammed bin Rashid al-Maktoum, is one of the world's largest thoroughbred owners and sponsors the richest horse racing day, the Dubai World Cup. "The Central Veterinary Research Laboratory will be an excellent partner in bringing this technology from the US to the Middle East as they are already the most respected reference lab in the region," says Dr. Bob Harman, CEO of Vet-Stem. The CVRL intends to provide stem cell services for treatment of injuries in thoroughbred race horses, Arabian endurance horses, racing camels, and many other species. Vet-Stem's clients in the United States have already treated over 2500 horses and over 100 dogs with arthritis, tendon, and ligament injuries with a success rate of over 70% return to normal performance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060425/VETSTEMLOGO)

Vet-Stem delivers stem and other regenerative cells from a small fat sample for use in treating an animal's own injuries. This clearly avoids the controversy of using stem cells taken from embryos. This technology provides the opportunity for regeneration and healing of tendon and ligament injuries instead of the normal scarring process which reduces performance and may increase chances of re-injury. Stem cells are delivered to the veterinarian only 48 hours after a small fat sample is collected from the injured animal. Priority overnight shipment has allowed Vet-Stem to develop veterinary clients in all parts of the country and has eliminated regional issues typically associated with service expansion. "Our success in animals is directly translatable to humans, said Robert J. Harman, DVM, MPVM CEO Vet-Stem, Inc., "and we wish to share our evidence that stem cells are safe and effective".

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals.

In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. Since that time there has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Studies have shown that mesenchymal stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.

For additional information, contact:

Vet-Stem, Inc.

Dr. Julie Ryan Johnson

12860 Danielson Court, Suite BPoway, CA 92064

858-748-2004

info@vet-stem.com


'/>"/>
SOURCE Vet-Stem, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Madison start-up Central Signal gets $350K grant
2. Will wireless Internet bypass the central city?
3. Norlight to expand fiber network into central Illinois
4. Centralization mania takes over
5. Meterologix Media Division acquired by Madison-based Weather Central
6. Weather Central launches second satellite
7. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
8. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
9. Control Your siRNA Research
10. Getting Started with MicroRNA Research
11. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Alex,s Lemonade Stand Foundation ... that it will open a state-of-the-art bioinformatics lab, using ... research. This announcement comes as Liz Scott , ... National Cancer Moonshot Summit in Washington, D.C. ... as a participant and advocate of pediatric cancer research ...
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... 2016  Sequenom, Inc. (NASDAQ: SQNM ), ... through the development of innovative products and services, announced ... United States denied its petition to review ... Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are not ... the Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories ...
Breaking Biology Technology:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):